204 related articles for article (PubMed ID: 31362878)
1. Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.
Chamberlain AM; Cohen SS; Killian JM; Monda KL; Weston SA; Okerson T
Am J Cardiol; 2019 Oct; 124(7):995-1001. PubMed ID: 31362878
[TBL] [Abstract][Full Text] [Related]
2. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.
Ferrières J; Gorcyca K; Iorga ŞR; Ansell D; Steen DL
Clin Ther; 2018 Sep; 40(9):1484-1495.e22. PubMed ID: 30126705
[TBL] [Abstract][Full Text] [Related]
4. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
5. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.
Steen DL; Khan I; Becker L; Foody JM; Gorcyca K; Sanchez RJ; Giugliano RP
Clin Cardiol; 2017 Mar; 40(3):155-162. PubMed ID: 28026031
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
[TBL] [Abstract][Full Text] [Related]
8. Intensive statin therapy for Indians: Part-I. Benefits.
Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
[TBL] [Abstract][Full Text] [Related]
9. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
[TBL] [Abstract][Full Text] [Related]
10. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
11. FACTORS INFLUENCING ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS IN MEXICO: THE INTERNATIONAL CHOLESTEROL MANAGEMENT PRACTICE STUDY.
Bello-Chavolla OY; Aguilar-Salinas CA
Rev Invest Clin; 2019; 71(6):408-416. PubMed ID: 31823964
[TBL] [Abstract][Full Text] [Related]
12. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
[TBL] [Abstract][Full Text] [Related]
13. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.
Nichols GA; Philip S; Reynolds K; Granowitz CB; Fazio S
Diabetes Obes Metab; 2019 Feb; 21(2):366-371. PubMed ID: 30225881
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease.
Kim MK; Han K; Joung HN; Baek KH; Song KH; Kwon HS
Cardiovasc Diabetol; 2019 Oct; 18(1):139. PubMed ID: 31640795
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
[TBL] [Abstract][Full Text] [Related]
16. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).
Danchin N; Almahmeed W; Al-Rasadi K; Azuri J; Berrah A; Cuneo CA; Karpov Y; Kaul U; Kayıkçıoğlu M; Mitchenko O; Ruiz AJ; Aguilar Salinas CA; Santos RD; Mercier F; Blom D;
Eur J Prev Cardiol; 2018 Jul; 25(10):1087-1094. PubMed ID: 29771156
[TBL] [Abstract][Full Text] [Related]
17. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY
Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839
[TBL] [Abstract][Full Text] [Related]
18. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
[TBL] [Abstract][Full Text] [Related]
19. Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study.
Ersbøll AK; Kristensen MS; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Lytken Larsen M; Green A
PLoS One; 2023; 18(5):e0286376. PubMed ID: 37256879
[TBL] [Abstract][Full Text] [Related]
20. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
